X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. VENUS REMEDIES FDC LTD./
VENUS REMEDIES
 
P/E (TTM) x 17.5 -819.1 - View Chart
P/BV x 3.6 0.2 1,520.8% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 FDC LTD.   VENUS REMEDIES
EQUITY SHARE DATA
    FDC LTD.
Mar-14
VENUS REMEDIES
Mar-16
FDC LTD./
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs144218 65.8%   
Low Rs7982 96.2%   
Sales per share (Unadj.) Rs47.6365.6 13.0%  
Earnings per share (Unadj.) Rs7.61.5 512.1%  
Cash flow per share (Unadj.) Rs9.037.9 23.8%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5382.5 12.4%  
Shares outstanding (eoy) m177.8311.44 1,554.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.4 569.9%   
Avg P/E ratio x14.6101.0 14.5%  
P/CF ratio (eoy) x12.34.0 312.0%  
Price / Book Value ratio x2.30.4 596.7%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7841,717 1,152.5%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m1,221324 376.2%   
Avg. sales/employee Rs ThNM4,100.7-  
Avg. wages/employee Rs ThNM318.0-  
Avg. net profit/employee Rs ThNM16.7-  
INCOME DATA
Net Sales Rs m8,4594,183 202.2%  
Other income Rs m39420 1,958.0%   
Total revenues Rs m8,8524,203 210.6%   
Gross profit Rs m2,070812 255.1%  
Depreciation Rs m249417 59.8%   
Interest Rs m31380 8.2%   
Profit before tax Rs m2,18435 6,221.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m60618 3,345.6%   
Profit after tax Rs m1,35317 7,959.7%  
Gross profit margin %24.519.4 126.1%  
Effective tax rate %27.751.6 53.8%   
Net profit margin %16.00.4 3,936.0%  
BALANCE SHEET DATA
Current assets Rs m4,3552,771 157.2%   
Current liabilities Rs m1,7921,931 92.8%   
Net working cap to sales %30.320.1 151.0%  
Current ratio x2.41.4 169.4%  
Inventory Days Days44125 35.5%  
Debtors Days Days2554 45.9%  
Net fixed assets Rs m3,0255,328 56.8%   
Share capital Rs m179114 156.1%   
"Free" reserves Rs m8,2434,177 197.3%   
Net worth Rs m8,4534,376 193.2%   
Long term debt Rs m111,911 0.6%   
Total assets Rs m10,5578,428 125.3%  
Interest coverage x71.41.1 6,537.4%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.80.5 161.4%   
Return on assets %13.14.7 278.5%  
Return on equity %16.00.4 4,120.9%  
Return on capital %23.56.6 356.2%  
Exports to sales %13.30-   
Imports to sales %3.320.5 16.3%   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283858 32.9%   
Fx inflow Rs m1,1460-   
Fx outflow Rs m355858 41.4%   
Net fx Rs m791-858 -92.1%   
CASH FLOW
From Operations Rs m1,485469 316.7%  
From Investments Rs m-62029 -2,121.6%  
From Financial Activity Rs m-753-464 162.4%  
Net Cashflow Rs m11335 327.0%  

Share Holding

Indian Promoters % 68.9 32.9 209.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 0.2 2,611.1%  
FIIs % 7.5 0.6 1,293.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 66.4 28.6%  
Shareholders   23,730 20,121 117.9%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ELDER PHARMA  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  GSK PHARMA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 18, 2017 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS